COVID-19: Covaxin`s paediatric trials may begin in June, Bharat Biotech expects WHO approval by end of Q3 or Q4

Dr Raches Ella also said that Bharat Biotech will be ramping up the manufacturing capacity of Covaxin to 700 million doses by the end of this year.